iRhythm Technologies Future Growth
Future criteria checks 4/6
iRhythm Technologies is forecast to grow earnings and revenue by 70% and 15% per annum respectively. EPS is expected to grow by 68.8% per annum. Return on equity is forecast to be -17.1% in 3 years.
Key information
70.0%
Earnings growth rate
68.8%
EPS growth rate
| Medical Equipment earnings growth | 14.2% |
| Revenue growth rate | 15.0% |
| Future return on equity | -17.1% |
| Analyst coverage | Good |
| Last updated | 01 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 796 | -25 | 6 | 105 | 9 |
| 12/31/2025 | 681 | -59 | -33 | 65 | 12 |
| 12/31/2024 | 585 | -119 | -255 | -42 | 12 |
| 9/30/2024 | 560 | -151 | -87 | -32 | N/A |
| 6/30/2024 | 537 | -132 | -96 | -55 | N/A |
| 3/31/2024 | 513 | -130 | -113 | -71 | N/A |
| 12/31/2023 | 493 | -123 | -91 | -50 | N/A |
| 9/30/2023 | 473 | -105 | -56 | -22 | N/A |
| 6/30/2023 | 452 | -99 | -50 | -19 | N/A |
| 3/31/2023 | 430 | -105 | -48 | -15 | N/A |
| 12/31/2022 | 411 | -116 | -53 | -23 | N/A |
| 9/30/2022 | 380 | -128 | -76 | -49 | N/A |
| 6/30/2022 | 362 | -131 | -69 | -35 | N/A |
| 3/31/2022 | 341 | -124 | -64 | -35 | N/A |
| 12/31/2021 | 323 | -101 | -66 | -38 | N/A |
| 9/30/2021 | 320 | -79 | -43 | -17 | N/A |
| 6/30/2021 | 306 | -59 | -42 | -24 | N/A |
| 3/31/2021 | 276 | -63 | -48 | -33 | N/A |
| 12/31/2020 | 265 | -44 | -27 | -14 | N/A |
| 9/30/2020 | 245 | -51 | -49 | -26 | N/A |
| 6/30/2020 | 228 | -65 | -59 | -38 | N/A |
| 3/31/2020 | 230 | -55 | -49 | -27 | N/A |
| 12/31/2019 | 215 | -55 | -42 | -22 | N/A |
| 9/30/2019 | 197 | -54 | -32 | -21 | N/A |
| 6/30/2019 | 181 | -45 | -34 | -26 | N/A |
| 3/31/2019 | 165 | -48 | -39 | -33 | N/A |
| 12/31/2018 | 147 | -50 | -34 | -29 | N/A |
| 9/30/2018 | 134 | -45 | -33 | -28 | N/A |
| 6/30/2018 | 120 | -42 | N/A | -27 | N/A |
| 3/31/2018 | 108 | -35 | N/A | -22 | N/A |
| 12/31/2017 | 99 | -30 | N/A | -15 | N/A |
| 9/30/2017 | 89 | -25 | N/A | -12 | N/A |
| 6/30/2017 | 81 | -22 | N/A | -11 | N/A |
| 3/31/2017 | 73 | -20 | N/A | -14 | N/A |
| 12/31/2016 | 64 | -21 | N/A | -17 | N/A |
| 9/30/2016 | 56 | -22 | N/A | -21 | N/A |
| 6/30/2016 | 49 | -24 | N/A | -24 | N/A |
| 3/31/2016 | 41 | -24 | N/A | -24 | N/A |
| 12/31/2015 | 36 | -23 | N/A | -18 | N/A |
| 9/30/2015 | 32 | -19 | N/A | -17 | N/A |
| 12/31/2014 | 22 | -16 | N/A | -16 | N/A |
| 12/31/2013 | 15 | -14 | N/A | -12 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: I25 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: I25 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: I25 is expected to become profitable in the next 3 years.
Revenue vs Market: I25's revenue (15% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: I25's revenue (15% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: I25 is forecast to be unprofitable in 3 years.